Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2025	Dec. 31, 2024
Investments:
Available-for-sale, Debt Securities, Excluding Securities Valued at Fair Value Option	$ 20,397	$ 17,848
Fixed maturities, at fair value using the fair value option	1,168	1,197
Equity Securities, FV-NI, Current	74	66
Other Short-Term Investments	33	20
Financing Receivable, after Allowance for Credit Loss, Current	4,412	3,613
Policy loans	159	163
Limited partnerships/corporations	1,309	1,227
Derivatives	142	239
Other investments	117	94
Total investments	28,811	25,556
Cash and cash equivalents	320	516
Short-term investments under securities loan agreements, including collateral delivered	828	839
Accrued investment income	311	276
Premiums and Other Receivables, Net	2,460	2,560
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net	1,265	907
Deferred Income Tax Assets, Net	502	662
Other assets	2,638	1,396
Assets held in separate accounts	108,695	98,579
Total assets	145,830	131,291
Liabilities and Shareholder's Equity
Future policy benefits and contract owner account balances	32,902	29,268
Payables under securities loan and repurchase agreements, including collateral held	938	897
Related Party [Member]	94	100
Derivatives	238	268
Other liabilities	676	639
Liabilities related to separate accounts	108,695	98,579
Total liabilities	143,543	129,751
Commitments and Contingencies (Note 13)
Shareholder's equity:
Common Stock, Value, Issued	3	3
Additional paid-in capital	2,929	2,754
Accumulated other comprehensive income (loss)	(1,116)	(1,644)
Retained earnings (deficit)	471	427
Total shareholder's equity	2,287	1,540
Total liabilities and shareholder's equity	145,830	131,291
Collateral Pledged
Investments:
Debt Securities, Available-for-Sale, Restricted	$ 1,000	$ 1,089